Basit öğe kaydını göster

dc.contributor.authorBeyazal, Mehmet
dc.contributor.authorKaba, Esat
dc.date.accessioned2025-08-14T07:22:01Z
dc.date.available2025-08-14T07:22:01Z
dc.date.issued2025en_US
dc.identifier.citationBeyazal, M., & Kaba, E. (2025). Effectiveness of Endovascular Treatment in Native Hemodialysis Fistula Dysfunction: Long-Term Outcomes. Journal of Clinical Medicine, 14(12), 4382. https://doi.org/10.3390/jcm14124382en_US
dc.identifier.issn2077-0383
dc.identifier.urihttps://doi.org/10.3390/jcm14124382
dc.identifier.urihttps://hdl.handle.net/11436/10896
dc.description.abstractObjectives: This study aimed to present our single-center experience on the efficacy of endovascular treatment for the dysfunction of hemodialysis arteriovenous fistulas (AVF). Methods: This retrospective study analyzed 110 patients with hemodialysis AVF dysfunction who underwent endovascular treatment. Patients were evaluated with Doppler ultrasound, and those with significant stenosis or thrombosis were treated using balloon angioplasty, tissue plasminogen activator (t-PA), and/or thrombectomy, or a combination of both. A transvenous approach was performed in all cases, and post-procedural patency was assessed with fistulography. The primary outcome was defined as achieving stenosis reduction below 30%, with follow-up patency recorded at 3 and 6 months. Long-term fistula patency times and the frequency of repeat interventions were also evaluated. Statistical analysis was conducted to evaluate patency outcomes and procedural success rates. Results: Primary patency was achieved in 90.9% of patients, with balloon angioplasty significantly improving patency rates (p = 0.0077), while t-PA and thrombectomy showed no significant impact. At the 3-month follow-up, 83% of patients maintained patency; at 6 months, this rate decreased to 72.7%. ANOVA analysis showed no significant differences between treatment groups in long-term patency time (p = 0.322). The mean fistula patency duration was most prolonged in patients treated with balloon angioplasty alone (21.8 months), followed by those who received combination therapy (19.2 months), and shortest in those treated with only t-PA or thrombectomy (14.7 months). However, differences were not statistically significant (p > 0.05). A total of 21 patients required repeat interventions, with an average patency duration of 25.13 months after reintervention. Conclusions: This study suggests that endovascular treatment, especially balloon angioplasty, plays a key role in maintaining fistula patency.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAngioplastyen_US
dc.subjectAVFen_US
dc.subjectEndovascular treatmenten_US
dc.subjectHemodialysisen_US
dc.subjectPatencyen_US
dc.titleEffectiveness of endovascular treatment in native hemodialysis fistula dysfunction: long-term outcomesen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorBeyazal, Mehmet
dc.contributor.institutionauthorKaba, Esat
dc.identifier.doi10.3390/jcm14124382en_US
dc.identifier.volume14en_US
dc.identifier.issue12en_US
dc.identifier.startpage4382en_US
dc.relation.journalJournal of Clinical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster